The Deep Vein Thrombosis Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Deep Vein Thrombosis Market:
https://www.thebusinessresearchcompany.com/report/deep-vein-thrombosis-global-market-report
According to The Business Research Company’s Deep Vein Thrombosis Global Market Report 2024, The deep vein thrombosis market size has grown steadily in recent years. It will grow from $1.03 billion in 2023 to $1.07 billion in 2024 at a compound annual growth rate (CAGR) of 4.5%. The growth in the historic period can be attributed to increased vascular medicine specialization, influence of medical guidelines, focus on thrombosis prevention, clinical research development, increased diagnosis awareness.
The deep vein thrombosis market size is expected to see steady growth in the next few years. It will grow to $1.26 billion in 2028 at a compound annual growth rate (CAGR) of 4.1%. The growth in the forecast period can be attributed to growing aging population, rising incidence of lifestyle diseases, preventive healthcare emphasis, innovative therapies, focus on patient-centric care. Major trends in the forecast period include risk factors awareness, advancements in diagnosis, treatment innovations, public health initiatives, post-surgical prevention.
The increasing number of individuals who require deep vein thrombosis (DVT) treatment is expected to propel the growth of the deep vein thrombosis market going forward. DVT treatment refers to treating patients with deep vein thrombosis using drugs such as anticoagulants and others that prevent the formation of new blood clots and existing blood clots from getting larger, alleviating the disease condition. The increase in the number of patients requiring DVT treatment indicates an increase in the prevalence of deep vein thrombosis that requires products for DVT diagnosis, prevention, and treatment. For instance, in February 2023, according to the Centers for Disease Control and Prevention (CDC), a US-based national public health agency, an overall 900,000 people could be affected each year in the United States due to deep vein thrombosis, and between 60,000 and 100,000 Americans die each year from DVT or PE (pulmonary embolism). Therefore, the increasing number of individuals requiring deep vein thrombosis (DVT) treatment is driving the market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=10616&type=smp
The deep vein thrombosis market covered in this report is segmented –
1) By Drug Class: Anticoagulants, Inferior Vena Cava Filters, Other Drug Class
2) By Treatment: Surgery, Drugs, Other Treatments
3) By Mode Of Administration: Injectable, Oral, Other Modes Of Action
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
5) By End User: Hospitals, Homecare, Specialty Clinics, Other End-users
Product innovations are a key trend gaining popularity in the deep vein thrombosis market. Major companies operating in the deep vein thrombosis market are adopting new technologies to develop new product and to sustain their position in the market. For instance, in January 2023, Penumbra Inc., a US-based developer of innovative therapies, launched Lightning Flash, an advanced and powerful mechanical thrombectomy system for addressing venous and pulmonary thrombus. The system features Penumbra's novel lightning-intelligent aspiration technology and innovative dual clot detection algorithms. It is designed to quickly remove large blood clots in the body, including venous thrombus and pulmonary emboli (PE). It provides physicians with a high torque-able, larger catheter designed for efficiently removing a significant clot burden in the pulmonary arteries or deep venous system while maintaining an excellent safety profile.
The deep vein thrombosis market report table of contents includes:
Executive Summary
Deep Vein Thrombosis Market Characteristics
Deep Vein Thrombosis Market Trends And Strategies
Deep Vein Thrombosis Market - Macro Economic Scenario
Global Deep Vein Thrombosis Market Size and Growth
.
.
.
Global Deep Vein Thrombosis Market Competitive Benchmarking
Global Deep Vein Thrombosis Market Competitive Dashboard
Key Mergers And Acquisitions In The Deep Vein Thrombosis Market
Deep Vein Thrombosis Market Future Outlook and Potential Analysis
Appendix
Top 5 Major Key Players Are:
Abbott Laboratories
Bristol-Myers Squibb Company
Sanofi-Aventis U.S. LLC
Daiichi Sankyo Company Limited
Aspen Pharmacare Holdings Limited
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
What is a DVT?A DVT is a blood clot that forms in a vein deep in your body.
It can develop in any of your veins, but most commonly occurs in the legs.
You may experience leg pain or swelling with a DVT, but in many cases, there are no symptoms.You may be at risk of developing a DVT if you sit for a prolonged period of time, as is the case when you take a long flight on an airplane.
You may also be at risk if you’re overweight or obese, have a blood clotting disorder, smoke cigarettes, or’re over the age of 60.If you are suffering from deep vein thrombosis and looking for an expert vascular surgeon in Johns Creek, you may get in touch with North Atlanta Vascular Clinic and Vein Center.
